Avadel Pharmaceuticals plc (AVDL)
Free
No email, no account, no signup.
Pulling latest news for Avadel Pharmaceuticals plc…
Bull
Bear
Want the why behind the signal? Get the deep 4-model report — full bull/bear, dated catalysts, dilution risk, weekly refresh. $4.99.
Get the deep 4-model report – $4.99
Order analysis – $4.99
Not satisfied? Get your money back within 7 days — no questions asked.
7-day money-back guarantee · No lock-in period · Secure payment via Stripe
Exchange
NASDAQ
Type
Biotech
Sector
Biopharmaceuticals for sleep disorders
Market Cap
$2.1B
We're already tracking Avadel Pharmaceuticals plc — here are the latest events we've registered
Recent News
- On February 12, 2026, Alkermes plc completed its acquisition of Avadel Pharmaceuticals following shareholder approval and Irish High Court sanctioning. As a result of the transaction, Avadel's ordinary shares were delisted from the NASDAQ Stock Market. The acquisition integrates Avadel's narcolepsy treatment, LUMRYZ, into the Alkermes commercial portfolio.
Want to know how this news affects Avadel Pharmaceuticals plc? Order the analysis.
Order analysis – $4.99
What you get
A complete express analysis — not just a signal. Delivered as a webpage in your account.
- Signal: BUY / HOLD / SELL — with clear reasoning
- Sentiment score 1–10 based on news, reports, and market data
- Risk score 1–10 (dilution, jurisdiction, execution)
- Bull case: 3–5 specific points with evidence (e.g. "Oversold after panic-reaction to security news, opening a technical bounce setup")
- Bear case: 3–5 specific risks (e.g. "Extreme uncertainty around the security situation in Sinaloa after tragic events")
- Upcoming catalysts with dates
- Assessment of dilution risk
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Avadel Pharmaceuticals plc will be delivered in the same format.
Not satisfied? Get your money back within 7 days — no questions asked.
The information on this page does not constitute investment advice. AI-generated analyses may contain errors. Always conduct your own research before making investment decisions. Firelda.ai is not responsible for any potential losses.